What Real-Time Supply Chain Visibility Means for Pharma
Real-time pharmaceutical supply chain visibility is the continuous, end-to-end digital tracking of serialized medicines from packaging lines to export dispatch, giving manufacturers actionable insight into product status, location, and compliance at every step. For life sciences organizations, this visibility depends on reliable serialization, data integration, and analytics that expose issues as they arise instead of days or weeks later. As global regulations demand precise drug traceability, companies are moving away from fragmented systems that hide data in silos and slow down response times. Instead, they are adopting unified, AI-enabled platforms that connect packaging equipment, enterprise systems, and regulatory reporting gateways. This shift is not only about staying compliant; it is also about reducing manual tracking, cutting processing delays, and improving decision-making across complex export networks. Annora Pharma’s rollout with AltiusHub shows how this transformation is taking shape in practice.
Inside the Annora–AltiusHub Deployment
Annora Pharma, a formulations subsidiary of the Hetero Group, is expanding its use of AltiusHub’s AI-native serialization, track-and-trace, and compliance platform across export operations. The project targets a reported improvement in serialization efficiency of up to 45%, while giving teams unified oversight of the pharmaceutical supply chain from packaging floor to international dispatch. Annora plans to reach real-time visibility across 100% of serialized drug products within three months, covering every step from the Level 3 packaging infrastructure through aggregation and export processes. This replaces multiple legacy tools with a single platform that can handle serialization, multi-market reporting, and automated exception handling. According to Dr Bhaskar Reddy, Director at Hetero Group, AltiusHub has enabled teams to manage serialization and traceability workflows with more transparency and independence, addressing long-standing pain points around limited data access and vendor-dependent systems.
Serialization Efficiency: From Bottleneck to Advantage
Serialization has long been seen as a compliance cost rather than an efficiency opportunity. By tying each saleable unit to a unique code and traceable data trail, manufacturers must process huge data volumes at speed. AltiusHub’s deployment at Annora shows how AI can turn this into an operational advantage. The platform’s AI-driven analytics speed up serialization processing and improve packaging floor productivity by spotting bottlenecks and managing exceptions automatically. Faster, more accurate serialization reduces rework and manual data corrections, improving both throughput and data quality. With an expected 45% gain in serialization efficiency, Annora can treat regulatory requirements as a driver of performance, not just an obligation. This reframes serialization from a narrow task into a foundation for stronger supply chain visibility, more reliable export documentation, and more precise drug traceability across markets with complex rules.
AI, Compliance, and Global Drug Traceability
Export-focused manufacturers must align drug traceability with a web of regulations, including DSCSA in the United States, FMD in the European Union, and frameworks in GCC, LATAM, and ASEAN markets. AltiusHub’s platform is designed to support compliance reporting across more than 50 regulated destinations through a unified data model rather than bespoke interfaces for each market. This approach limits repetitive manual work and reduces the risk of errors in regulatory submissions. Automated exception management helps compliance and operations teams resolve issues faster, which is vital when shipment holds or data mismatches can disrupt supply. By consolidating serialization, aggregation, and reporting, pharma companies gain consistent supply chain visibility while meeting traceability mandates for both commercial exports and public health programs. The result is a digital backbone that supports safer, more transparent movement of medicines across borders.
Why Manual Tracking Is Giving Way to Digital Oversight
Many pharmaceutical manufacturers still rely on spreadsheets, email chains, and disconnected reporting tools to track serialized products as they move through the export supply chain. These manual processes are error-prone, slow, and hard to audit. With AI-native platforms like AltiusHub, data from packaging lines, warehouses, and trade systems flows into a single environment, improving data accuracy and cutting routine paperwork. Operations teams gain supply chain visibility in the form of real-time dashboards, alerts, and exception queues instead of static reports. As Mr Sridhar Reddy, Operations Head at Annora Pharma, notes, the company needed systems that give teams real-time visibility, faster issue resolution, and stronger control over compliance workflows. This digital shift supports not only regulatory demands but also business goals: more predictable exports, fewer delays at borders, and a clearer picture of where every serialized unit is at any time.